Rate and causes of noncompliance with disease-modifying antirheumatic drug regimens in patients with rheumatoid arthritis

被引：0
作者：
Wanruchada Katchamart
Pongthorn Narongroeknawin
Ngamsiree Sukprasert
Wanwisa Chanapai
Ananya Srisomnuek
机构：
[1] Mahidol University,Division of Rheumatology, Department of Medicine, Faculty of Medicine Siriraj Hospital
[2] Phramongkutklao Hospital and College of Medicine,Division of Rheumatology, Department of Medicine
[3] Mahidol University,Department of Medicine, Faculty of Medicine Siriraj Hospital
[4] Mahidol University,Division of Clinical Trials, Research Department, Faculty of Medicine Siriraj Hospital
来源：
Clinical Rheumatology | 2021年 / 40卷
关键词：
Compliance-Questionnaire-Rheumatology; Medication compliance; Rheumatoid arthritis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1291 / 1298
页数：7
相关论文
共 50 条
[41]   The effect of disease-modifying antirheumatic drugs (DMARDs) on bone homeostasis in rheumatoid arthritis (RA) patients [J].
Khoshroo, Ahmadreza ;
Ramezani, Keyvan ;
Moghimi, Niusha ;
Bonakdar, Moein ;
Ramezani, Nazanin .
INFLAMMOPHARMACOLOGY, 2023, 31 (02) :689-697
[42]   Comparative effectiveness of JAK inhibitors and biologic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis [J].
Cho, Soo-Kyung ;
Kim, Hyoungyoung ;
Song, Yeo-Jin ;
Kim, Hye Won ;
Nam, Eunwoo ;
Lee, Shin-Seok ;
Lee, Hye-Soon ;
Park, Sung-Hoon ;
Lee, Yeon-Ah ;
Park, Min-Chan ;
Chang, Sung Hae ;
Kim, Hyoun-Ah ;
Kwok, Seung-Ki ;
Kim, Hae-Rim ;
Kim, Hyun-Sook ;
Yoon, Bo Young ;
Uhm, Wan-Sik ;
Kim, Yong-Gil ;
Kim, Jae Hoon ;
Lee, Jisoo ;
Choi, Jeongim ;
Sung, Yoon-Kyoung .
KOREAN JOURNAL OF INTERNAL MEDICINE, 2023, 38 (04) :546-+
[43]   The effect of disease-modifying antirheumatic drugs (DMARDs) on bone homeostasis in rheumatoid arthritis (RA) patients [J].
Ahmadreza Khoshroo ;
Keyvan Ramezani ;
Niusha Moghimi ;
Moein Bonakdar ;
Nazanin Ramezani .
Inflammopharmacology, 2023, 31 :689-697
[44]   Biologic Disease-Modifying Antirheumatic Drug Prescription Patterns for Rheumatoid Arthritis Among United States Physicians [J].
Sullivan, Emma ;
Kershaw, Jim ;
Blackburn, Stuart ;
Choi, Jeannie ;
Curtis, Jeffrey R. ;
Boklage, Susan .
RHEUMATOLOGY AND THERAPY, 2020, 7 (02) :383-400
[45]   Biologic Disease-Modifying Antirheumatic Drug Prescription Patterns for Rheumatoid Arthritis Among United States Physicians [J].
Emma Sullivan ;
Jim Kershaw ;
Stuart Blackburn ;
Jeannie Choi ;
Jeffrey R. Curtis ;
Susan Boklage .
Rheumatology and Therapy, 2020, 7 :383-400
[46]   Patterns of biologic and targeted-synthetic disease-modifying antirheumatic drug use in rheumatoid arthritis in Australia [J].
Fletcher, Ashley ;
Lassere, Marissa ;
March, Lyn ;
Hill, Catherine ;
Barrett, Claire ;
Carroll, Graeme ;
Buchbinder, Rachelle .
RHEUMATOLOGY, 2022, 61 (10) :3939-3951
[47]   Update on the use of conventional disease-modifying antirheumatic drugs in the management of rheumatoid arthritis [J].
Feely, Michael G. ;
O'Dell, James R. .
CURRENT OPINION IN RHEUMATOLOGY, 2010, 22 (03) :316-320
[48]   Pharmacotherapeutic combination strategies with disease-modifying antirheumatic drugs in established rheumatoid arthritis [J].
van Riel, PLCM ;
Haagsma, CJ ;
Furst, DE .
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 1999, 13 (04) :689-700
[49]   The Risk of Cardiovascular Events Associated With Disease-modifying Antirheumatic Drugs in Rheumatoid Arthritis [J].
Ozen, Gulsen ;
Pedro, Sofia ;
Michaud, Kaleb .
JOURNAL OF RHEUMATOLOGY, 2021, 48 (05) :648-655
[50]   Pharmacogenetics of disease-modifying antirheumatic drugs in rheumatoid arthritis: towards personalized medicine [J].
Mirkov, Masa Umicevic ;
Coenen, Marieke J. H. .
PHARMACOGENOMICS, 2013, 14 (04) :425-444
12345